March 2, 2020   Consensus group redefines, standardizes AMD classifications An internationally renowned working group of retina specialists, ocular imaging experts, and ocular pathologists has suggested standardizing definitions for age-related macular degeneration (AMD) and its subtypes. Learn more ADVERTISEMENT   PRN ranibizumab outcomes over the long term in real world Nearly 50% of eyes with wet age-related macular degeneration (AMD) have stable or improved vision after long-term, 8-year pro re nata (PRN) treatment with ranibizumab, according to a group of U.K. clinicians. Learn more ADVERTISEMENT Novel patient-specific, stem cell-based therapy to treat GA Researchers at the National Eye Institute are launching a clinical trial to test the safety of a novel patient-specific, stem cell-based therapy to treat geographic atrophy. Learn more   RELATED ARTICLES Prosthesis system may help blind patients 'see' again AMD awareness: Close focus on preserving vision What non-retina specialists need to know about dry AMD Coming to terms with ‘ultra-widefield’ and ‘widefield’ imaging